You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Therapeutic drug monitoring of amikacin in septic patients
|
|---|---|
| Published in |
Critical Care, July 2013
|
| DOI | 10.1186/cc12844 |
| Pubmed ID | |
| Authors |
Wieslawa Duszynska, Fabio Silvio Taccone, Magdalena Hurkacz, Beata Kowalska-Krochmal, Anna Wiela-Hojeńska, Andrzej Kübler |
| Abstract |
Use of higher than standard doses of amikacin (AMK) has been proposed during sepsis, especially to treat less susceptible bacterial strains. However, few data are available on drug concentrations during prolonged therapy and on potential adverse events related to this strategy. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 14% |
| Canada | 1 | 14% |
| Unknown | 5 | 71% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 4 | 57% |
| Members of the public | 3 | 43% |
Mendeley readers
The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 2% |
| United Kingdom | 1 | <1% |
| Colombia | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 121 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 16% |
| Student > Bachelor | 19 | 15% |
| Student > Master | 14 | 11% |
| Student > Postgraduate | 12 | 10% |
| Other | 9 | 7% |
| Other | 32 | 25% |
| Unknown | 20 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 49 | 39% |
| Pharmacology, Toxicology and Pharmaceutical Science | 37 | 29% |
| Agricultural and Biological Sciences | 5 | 4% |
| Unspecified | 2 | 2% |
| Chemistry | 2 | 2% |
| Other | 6 | 5% |
| Unknown | 25 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2013.
All research outputs
#6,963,859
of 25,374,917 outputs
Outputs from Critical Care
#3,892
of 6,554 outputs
Outputs of similar age
#55,949
of 209,991 outputs
Outputs of similar age from Critical Care
#37
of 105 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 6,554 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,991 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.